These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26167239)

  • 1. Effects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials.
    Song K; Wang S; Qi D
    Oxid Med Cell Longev; 2015; 2015():287058. PubMed ID: 26167239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
    Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
    Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine A.
    Liu L; Zhu J; Brink PR; Glass PS; Rebecchi MJ
    Acta Anaesthesiol Scand; 2011 May; 55(5):622-30. PubMed ID: 21827445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of different cyclosporine A doses on protection after myocardial ischemia/reperfusion injury in rat.
    Huang K; Lu SJ; Zhong JH; Xiang Q; Wang L; Wu M
    Asian Pac J Trop Med; 2014 Feb; 7(2):144-8. PubMed ID: 24461529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition.
    Leshnower BG; Kanemoto S; Matsubara M; Sakamoto H; Hinmon R; Gorman JH; Gorman RC
    Ann Thorac Surg; 2008 Oct; 86(4):1286-92. PubMed ID: 18805178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporine on reperfusion injury in acute myocardial infarction.
    Piot C; Croisille P; Staat P; Thibault H; Rioufol G; Mewton N; Elbelghiti R; Cung TT; Bonnefoy E; Angoulvant D; Macia C; Raczka F; Sportouch C; Gahide G; Finet G; André-Fouët X; Revel D; Kirkorian G; Monassier JP; Derumeaux G; Ovize M
    N Engl J Med; 2008 Jul; 359(5):473-81. PubMed ID: 18669426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
    Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
    Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cyclosporine in the treatment of myocardial reperfusion injury.
    Gill RS; Bigam DL; Cheung PY
    Shock; 2012 Apr; 37(4):341-7. PubMed ID: 22293599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cyclosporine A use in the prevention of reperfusion injury in acute myocardial infarction: A meta-analysis.
    Upadhaya S; Madala S; Baniya R; Subedi SK; Saginala K; Bachuwa G
    Cardiol J; 2017; 24(1):43-50. PubMed ID: 27734457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening of long-term myocardial function after successful pharmacological pretreatment with cyclosporine.
    Laudi S; Weimann J; Haschke M; Trump S; Schmitz V; Christians U; Kaisers U; Steudel W
    J Physiol Pharmacol; 2007 Mar; 58(1):19-32. PubMed ID: 17440223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting myocardial reperfusion injuries with cyclosporine in the CIRCUS Trial - pharmacological reasons for failure.
    Monassier L; Ayme-Dietrich E; Aubertin-Kirch G; Pathak A
    Fundam Clin Pharmacol; 2016 Apr; 30(2):191-3. PubMed ID: 26713664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine A, 2.5 mg/kg, does not reduce myocardial infarct size in a porcine model of ischemia and reperfusion.
    Karlsson LO; Bergh N; Grip L
    J Cardiovasc Pharmacol Ther; 2012 Jun; 17(2):159-63. PubMed ID: 21572075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine A, a Potential Therapy of Ischemic Reperfusion Injury. A Common History for Heart and Brain.
    Nighoghossian N; Ovize M; Mewton N; Ong E; Cho TH
    Cerebrovasc Dis; 2016; 42(5-6):309-318. PubMed ID: 27245840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction.
    Ghaffari S; Kazemi B; Toluey M; Sepehrvand N
    Cardiovasc Ther; 2013 Aug; 31(4):e34-9. PubMed ID: 23061531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of mitochondrial permeability transition pore inhibitors.
    Naryzhnaya NV; Maslov LN; Oeltgen PR
    Drug Dev Res; 2019 Dec; 80(8):1013-1030. PubMed ID: 31823411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
    Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
    Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
    Pagel PS; Krolikowski JG
    Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of mitochondrial permeability transition to prevent the post-cardiac arrest syndrome: a pre-clinical study.
    Cour M; Loufouat J; Paillard M; Augeul L; Goudable J; Ovize M; Argaud L
    Eur Heart J; 2011 Jan; 32(2):226-35. PubMed ID: 20430770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.